Sunshine Biopharma (SBFM) Other Non Operating Income (2016 - 2026)
Sunshine Biopharma's (SBFM) quarterly Other Non Operating Income came in at -$18.0 in Q1 2026, down 103.99% YoY from $451.0 in Q1 2025, and down 800.0% on a QoQ basis from -$2.0 in Q4 2025.
Sunshine Biopharma (SBFM) Other Non Operating Income (2016 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 11 years of Other Non Operating Income data on file, last reported at -$18.0 in Q1 2026.
- Quarterly Other Non Operating Income fell 103.99% year-over-year to -$18.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2173.0 (up 105.74% YoY) and the FY2025 annual result came in at $2642.0, up 105.99% from the prior year.
- Other Non Operating Income retreated to -$18.0 in Q1 2026, from -$2.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $286535.0 in Q2 2024 to a low of -$340003.0 in Q4 2024.
- A 5-year average of -$1844.5 and a median of $15.0 in 2023 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 109883.52% in 2024, down 871702.56% in 2024.
- Tracing SBFM's Other Non Operating Income over 5 years: stood at -$521.0 in 2022, then surged by 92.51% to -$39.0 in 2023, then tumbled by 871702.56% to -$340003.0 in 2024, then jumped by 100.0% to -$2.0 in 2025, then sank by 800.0% to -$18.0 in 2026.
- The last three Other Non Operating Income figures came in at -$18.0 (Q1 2026), -$2.0 (Q4 2025), and $253.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Sunshine Biopharma | 1.53 Mn | -12.22 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.00 |
| Mar 31, 2026 | -18.00 |
| Dec 31, 2025 | -2.00 |
| Sep 30, 2025 | 253.00 |
| Jun 30, 2025 | 1,940.00 |
| Mar 31, 2025 | 451.00 |
| Dec 31, 2024 | -340,003.00 |
| Sep 30, 2024 | 15,153.00 |
| Jun 30, 2024 | 286,535.00 |
| Mar 31, 2024 | -5,767.00 |
| Dec 31, 2023 | -39.00 |
| Sep 30, 2023 | 40.00 |
| Jun 30, 2023 | -261.00 |
| Mar 31, 2023 | 15.00 |
| Dec 31, 2022 | -521.00 |
| Sep 30, 2022 | 25.00 |
| Jun 30, 2022 | 10,852.00 |
| Mar 31, 2022 | -9.00 |
| Dec 31, 2021 | 19.00 |
| Sep 30, 2021 | 7,688.00 |